Management of an Immunocompromised Pediatric Patient
With Multiple Hospitalizations for Symptomatic COVID-19. Accepted by: J Pediatr Hematol Oncol. Publication pending.
DeVine MN, Maxwell S, Haynes AS, MacBrayne CE, Boguniewicz J. Management of an Immunocompromised Pediatric Patient With Multiple Hospitalizations for Symptomatic COVID-19. J Pediatr Hematol Oncol. 2020 Nov 23. [Epub ahead of print] PubMed PMID: 33235142
Haynes AS, Curtis DJ, Campbell K, Giller RH, Quinones RR, Verneris MR, Abzug MJ. An Immune Recovery-Based Revaccination Protocol for Pediatric Hematopoietic Stem Cell Transplant Recipients: Revaccination Outcomes Following Pediatric HSCT. Transplant Cell Ther. 2021 Apr;27(4):317-326. PubMed PMID: 33836875
Haynes AS, MacBrayne CE, Parker SK. Impact of Antimicrobial Stewardship Bundle on Inpatient Use of Highly Bioavailable Antibacterials. Hosp Pediatr. 2021 May;11(5):509-514. PubMed PMID: 33926913
DeVine MN, Maxwell S, Haynes AS, MacBrayne CE, Boguniewicz J. Management of an Immunocompromised Pediatric Patient With Multiple Hospitalizations for Symptomatic COVID-19. J Pediatr Hematol Oncol. 2022 Jan 1;44(1):e293-e295. PubMed PMID: 33235142
Haynes AS, Prinzi A, Silveira LJ, Parker SK, Lampe JN, Kavanaugh JS, Horswill AR, Fish D. Cefadroxil Comparable to Cephalexin: Minimum Inhibitory Concentrations among Methicillin-Susceptible Staphylococcus aureus Isolates from Pediatric Musculoskeletal Infections. Microbiol Spectr. 2022 Aug 31;10(4):e0103922. PubMed PMID: 35730963
Martin AM, MacBrayne CE, Heiden A, Child J, Curtis DJ, and Haynes AS, Isavuconazonium Sulfate Dosing in Pediatric Patients Using Serum Therapeutic Drug Monitoring at a Single Center: A Case Series. Journal of Hematology Oncology Pharmacy. 2022;12(5):271-277.
Haynes AS, Maples H, Parker S. Time for a Change: Considering Vancomycin Alternatives for Pediatric Methicillin-Resistant Staphylococcus aureus Bacteremia. J Pediatric Infect Dis Soc. 2023 May 31;12(5):308-318. PubMed PMID: 37144953
Haynes A, Wei Z, Anderson P, Scheetz MH, Parker SK, N D. 2946. Comparative Pharmacokinetics and Pharmacodynamics of Cefadroxil and Cephalexin for Pediatric Musculoskeletal Infections. Open Forum Infect Dis. 2023 Nov 27;10(Suppl 2):ofad500.185. doi: 10.1093/ofid/ofad500.185. PMCID: PMC10679111.
Morales Junior R, Amajor V, Paice K, Kyler KE, Hambrick HR, Pavia KE, Haynes AS, Gooden F, Pais GM, Downes KJ, Ramsey LB, Wagner J, Tang Girdwood S. From Dose to Exposure: Shifting the Paradigm of Pediatric Clinical Pharmacology Research and Education. Clin Pharmacol Ther. 2024 Sep;116(3):515-517. PubMed PMID: 38686743
Haynes AS, Wei Z, Anderson P, Scheetz MH, Parker SK, Fish DN. Cefadroxil and cephalexin pharmacokinetics and pharmacodynamics in children with musculoskeletal infections. Antimicrob Agents Chemother. 2024 May 2;68(5):e0018224. PubMed PMID: 38597672
Haynes, A.S. and O’Hara K. Skin and Soft Tissue Infections. In: Comprehensive Pediatric Hospital Medicine. 3rd ed. McGraw Hill; 2024
Cole L and Haynes A. Discitis. In: Cabana MD (ed). The 5-Minute Pediatric Consult. 9th ed. Philadelphia, PA: Wolters Kluwer; 2024.
Cole L and Haynes A. Kawasaki Disease. In: Cabana MD (ed). The 5-Minute Pediatric Consult. 9th ed. Philadelphia, PA: Wolters Kluwer; 2024.
Cole L and Haynes A. Lyme Disease. In: Cabana MD (ed). The 5-Minute Pediatric Consult. 9th ed. Philadelphia, PA: Wolters Kluwer; 2024.